email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2638-5910

Archives of Diabetes & Obesity

Review Article(ISSN: 2638-5910)

Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes

Volume 1 - Issue 3

Nikolaos Papanas* and Theano Penlioglou

  • Author Information Open or Close
    • Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

    *Corresponding author: Nikolaos Papanas, Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, G Kondyli 22c, Alexandroupolis 68100, Greece

Received: June 20, 2018;   Published: June 27, 2018

DOI: 10.32474/ADO.2018.01.000111

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Over the past years, type 2 diabetes mellitus (T2DM) has become a global pandemic, both in developed and developing countries [1,2]. Its aetiology is multifactorial, including genetic factors, increasing age, obesity and insulin resistance [3]. Among these factors, obesity is of paramount importance, and its management can be of benefit [4,5].

Editorial| Conflicts of Interest| References|

https://www.high-endrolex.com/21